Literature DB >> 14220675

IMMUNOCHEMICAL STUDIES ON THE TOBACCO MOSAIC VIRUS PROTEIN. I. THE IMMUNOLOGICAL RELATIONSHIP OF THE TRYPTIC PEPTIDES OF TOBACCO MOSAIC VIRUS PROTEIN TO THE WHOLE PROTEIN.

E BENJAMINI, J D YOUNG, M SHIMIZU, C Y LEUNG.   

Abstract

Entities:  

Keywords:  CHEMISTRY; COMPLEMENT FIXATION TESTS; EXPERIMENTAL LAB STUDY; IMMUNOCHEMISTRY; PEPTIDES; TOBACCO MOSAIC VIRUS; VIRAL PROTEINS

Mesh：

Substances：

Year:  1964        PMID： 14220675     DOI： 10.1021/bi00896a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.

Authors:  R Arnon; E Maron; M Sela; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

Review 2.  The antigenicity of tobacco mosaic virus.

Authors:  M H Van Regenmortel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-03-29       Impact factor: 6.237

3.  Sequence differences of Escherichia coli 30S ribosomal proteins as determined by immunochemical methods.

Authors:  G Stöffler; H G Wittmann
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

4.  Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.

Authors:  R Arnon; M Bustin; E Calef; S Chaitchik; J Haimovich; N Novik; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

5.  Antigenic heterology between flagellin and flagella of Bacillus subtilis.

Authors:  A T Ichiki; R J Martinez
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

6.  Studies on the immune response to a characterized antigenic determinant of the tobacco mosaic virus protein.

Authors:  L Spitler; E Benjamini; J D Young; H Kaplan; H H Fudenberg
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.